ZA931035B - Sulfonic acid derivatives in the treatment of viral diseases. - Google Patents
Sulfonic acid derivatives in the treatment of viral diseases.Info
- Publication number
- ZA931035B ZA931035B ZA931035A ZA931035A ZA931035B ZA 931035 B ZA931035 B ZA 931035B ZA 931035 A ZA931035 A ZA 931035A ZA 931035 A ZA931035 A ZA 931035A ZA 931035 B ZA931035 B ZA 931035B
- Authority
- ZA
- South Africa
- Prior art keywords
- sulfonic acid
- treatment
- acid derivatives
- viral diseases
- viral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/41—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
- C07C309/42—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/51—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C327/42—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
- C07C329/02—Monothiocarbonic acids; Derivatives thereof
- C07C329/04—Esters of monothiocarbonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
- C07C329/12—Dithiocarbonic acids; Derivatives thereof
- C07C329/14—Esters of dithiocarbonic acids
- C07C329/20—Esters of dithiocarbonic acids having sulfur atoms of dithiocarbonic groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C333/02—Monothiocarbamic acids; Derivatives thereof
- C07C333/08—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C333/14—Dithiocarbamic acids; Derivatives thereof
- C07C333/18—Esters of dithiocarbamic acids
- C07C333/24—Esters of dithiocarbamic acids having nitrogen atoms of dithiocarbamate groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83863992A | 1992-02-20 | 1992-02-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA931035B true ZA931035B (en) | 1993-09-17 |
Family
ID=25277670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA931035A ZA931035B (en) | 1992-02-20 | 1993-02-15 | Sulfonic acid derivatives in the treatment of viral diseases. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5359131A (de) |
| EP (1) | EP0626945B1 (de) |
| JP (1) | JP3309104B2 (de) |
| KR (1) | KR100275843B1 (de) |
| AT (1) | ATE165345T1 (de) |
| AU (1) | AU663925B2 (de) |
| CA (1) | CA2130360C (de) |
| DE (1) | DE69318136T2 (de) |
| ES (1) | ES2115756T3 (de) |
| IL (1) | IL104780A (de) |
| MX (1) | MX9300836A (de) |
| NZ (1) | NZ249032A (de) |
| TW (1) | TW224968B (de) |
| WO (1) | WO1993016992A1 (de) |
| ZA (1) | ZA931035B (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5670144A (en) * | 1990-07-09 | 1997-09-23 | Merrell Pharmaceuticals Inc. | Anti-herpes virus and cytomegalovirus polyester oligomers |
| US5276182A (en) * | 1990-07-09 | 1994-01-04 | The Dow Chemical Company | Process for preparing polyurea oligomers |
| US5424063A (en) * | 1992-01-09 | 1995-06-13 | The Dow Chemical Company | Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process |
| IL112174A (en) * | 1994-01-03 | 1999-05-09 | Merrell Dow Pharma | Oligomers of polythioureas pharmaceutical compositions containing them and a process for their preparation |
| WO1996025157A1 (en) | 1995-02-17 | 1996-08-22 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| US5681832A (en) * | 1995-02-17 | 1997-10-28 | The United States Of America As Represented By The Department Of Health And Human Services | Aroylaniline compounds, pharmaceutical compositions, and methods of using same to inhibit viral activity |
| BR9612004A (pt) * | 1995-12-15 | 1999-12-28 | Cryopreservation Thechnologies | Composição para criopreservação de orgão e tratamento de infecções virais e bacterianas |
| US5852015A (en) * | 1997-01-27 | 1998-12-22 | American Cyanamid Company | Triazine containing anionic compounds useful as antiviral agents |
| CN1163401A (zh) * | 1996-02-13 | 1997-10-29 | 李占元 | 全自动血球计数仪试剂及配制方法 |
| US6211373B1 (en) | 1996-03-20 | 2001-04-03 | Smithkline Beecham Corporation | Phenyl urea antagonists of the IL-8 receptor |
| US6262113B1 (en) | 1996-03-20 | 2001-07-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| TR199802695T2 (xx) | 1996-06-27 | 1999-04-21 | Smithkline Beecham Corporation | IL-8 Resept�r kar��tlar� |
| TR199802694T2 (xx) * | 1996-06-27 | 1999-03-22 | Smithkline Beecham Corporation | IL-8 resept�r kar��tlar� |
| ZA984649B (en) * | 1997-06-13 | 1999-12-17 | Cryopreservation Tech Cc | "Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes". |
| GB9928418D0 (en) * | 1999-12-01 | 2000-01-26 | Novartis Ag | Organic compounds |
| US6806366B2 (en) | 2001-02-02 | 2004-10-19 | Wyeth | Preparation and purification of antiviral disulfonic acid disodium salt |
| JP2007523073A (ja) * | 2004-02-04 | 2007-08-16 | アクテイブ・バイオテツク・アクテイエボラーグ | ジウレア誘導体 |
| BRPI0713792A8 (pt) * | 2006-06-27 | 2018-01-09 | Hadasit Medical Res Services And Development Limited | uso de derivados de estilbeno para tratamento e prevenção de infecções por fungos aquáticos |
| CA2671900A1 (en) * | 2006-12-22 | 2008-07-03 | The Regents Of The University Of California | Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| WO2010148177A2 (en) * | 2009-06-17 | 2010-12-23 | The Board Of Trustees Of The Leland Stanford Junior University | Compounds, compositions, methods of synthesis, and methods of treatment |
| TW201702218A (zh) * | 2014-12-12 | 2017-01-16 | 美國杰克森實驗室 | 關於治療癌症、自體免疫疾病及神經退化性疾病之組合物及方法 |
| JP2022514195A (ja) * | 2018-11-22 | 2022-02-10 | ユニバーシテ デ ナンテス | 増殖性疾患の処置で使用するためのジスルホナートスチルベン |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD39717A (de) * | ||||
| US2676982A (en) * | 1951-06-08 | 1954-04-27 | Gen Aniline & Film Corp | Fluorescent agents |
| BE660945A (de) * | 1964-03-12 | 1965-07-01 | ||
| US4107202A (en) * | 1977-03-28 | 1978-08-15 | American Cyanamid Company | Substituted 4,4'-biphenylylene bis(2-thioureylene)di-naphthalenetrisulfonic acids and salts thereof |
| US4328244A (en) * | 1980-05-21 | 1982-05-04 | The Dow Chemical Company | Novel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereof |
| US4349568A (en) * | 1980-06-12 | 1982-09-14 | The Dow Chemical Company | Sulfur-substituted diphenyl ethers having antiviral activity |
| US4435394A (en) * | 1981-12-17 | 1984-03-06 | Shionogi & Co., Ltd. | 3-Sulfonamido-benzophenonimine derivatives useful for treating virus infections |
| DE3528992A1 (de) * | 1985-08-13 | 1987-02-26 | Barthell Eduard | Sulfonamidderivate, verfahren zu ihrer herstellung und verwendung |
| DE3600046A1 (de) * | 1985-08-13 | 1987-07-09 | Barthell Eduard | Sulfonamidderivate, verfahren zu ihrer herstellung und verwendung |
| DE3530718A1 (de) * | 1985-08-28 | 1987-03-12 | Madaus & Co Dr | Methylendioxyphenanthren- und -stilbenderivate, verfahren zur herstellung derselben und arzneimittel, die diese enthalten |
| EP0221021B1 (de) * | 1985-10-16 | 1989-11-08 | Ciba-Geigy Ag | Bechamp-Reduktion von DNS zu DAS mit H2SO4 und Spuren von HOAc |
| DE3626309A1 (de) * | 1986-08-02 | 1988-02-18 | Stockhausen Chem Fab Gmbh | Antivirusmittel |
| US5276182A (en) * | 1990-07-09 | 1994-01-04 | The Dow Chemical Company | Process for preparing polyurea oligomers |
| DE69106493T2 (de) * | 1991-02-05 | 1995-06-29 | Merrell Dow Pharma | Sulfonische Stilbenderivate zur Behandlung von Viruserkrankungen. |
-
1993
- 1993-01-22 AT AT93903629T patent/ATE165345T1/de active
- 1993-01-22 AU AU34818/93A patent/AU663925B2/en not_active Expired
- 1993-01-22 CA CA002130360A patent/CA2130360C/en not_active Expired - Lifetime
- 1993-01-22 ES ES93903629T patent/ES2115756T3/es not_active Expired - Lifetime
- 1993-01-22 KR KR1019940702899A patent/KR100275843B1/ko not_active IP Right Cessation
- 1993-01-22 JP JP51484393A patent/JP3309104B2/ja not_active Expired - Lifetime
- 1993-01-22 EP EP93903629A patent/EP0626945B1/de not_active Expired - Lifetime
- 1993-01-22 NZ NZ249032A patent/NZ249032A/en unknown
- 1993-01-22 WO PCT/US1993/000564 patent/WO1993016992A1/en active IP Right Grant
- 1993-01-22 DE DE69318136T patent/DE69318136T2/de not_active Expired - Lifetime
- 1993-02-15 ZA ZA931035A patent/ZA931035B/xx unknown
- 1993-02-16 TW TW082101064A patent/TW224968B/zh active
- 1993-02-17 MX MX9300836A patent/MX9300836A/es not_active IP Right Cessation
- 1993-02-18 IL IL10478093A patent/IL104780A/en not_active IP Right Cessation
- 1993-08-13 US US08/106,311 patent/US5359131A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU3481893A (en) | 1993-09-13 |
| NZ249032A (en) | 1996-09-25 |
| MX9300836A (es) | 1993-09-01 |
| ATE165345T1 (de) | 1998-05-15 |
| JP3309104B2 (ja) | 2002-07-29 |
| US5359131A (en) | 1994-10-25 |
| DE69318136T2 (de) | 1998-10-22 |
| ES2115756T3 (es) | 1998-07-01 |
| TW224968B (de) | 1994-06-11 |
| IL104780A (en) | 1998-10-30 |
| KR950700245A (ko) | 1995-01-16 |
| AU663925B2 (en) | 1995-10-26 |
| IL104780A0 (en) | 1993-06-10 |
| JPH07504190A (ja) | 1995-05-11 |
| CA2130360C (en) | 1998-06-09 |
| EP0626945B1 (de) | 1998-04-22 |
| CA2130360A1 (en) | 1993-08-21 |
| WO1993016992A1 (en) | 1993-09-02 |
| DE69318136D1 (de) | 1998-05-28 |
| EP0626945A1 (de) | 1994-12-07 |
| KR100275843B1 (ko) | 2000-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL104780A0 (en) | Sulfonic acid derivatives in the treatment of viral diseases | |
| AU1062092A (en) | Sulfonic stilbene derivatives in the treatment of viral diseases | |
| AU1049788A (en) | Methods and peptides for the treatment of non-ige-mediated diseases | |
| NO985200L (no) | Antimikrobiell behandling for herpes simplex virus, og andre infeksi÷se syk | |
| PT966447E (pt) | Moleculas pequenas uteis no tratamento de doencas inflamatorias | |
| GB2244646B (en) | Anti-viral agents comprising a poly(ADP-ribose) polymerase inhibitor | |
| DE69131200D1 (en) | Herpes simplex virus vp16 impfstoffe | |
| DE3776999D1 (de) | Mittel zur vorbeugung gegen pflanzenviruskrankheiten. | |
| ES544787A0 (es) | Preparaciones medicinales solidas | |
| AU4445089A (en) | Lactamimides in the treatment of drug-resistant protozoal infections | |
| AU4088697A (en) | Postinfection human immunodeficiency virus (hiv) vaccination therapy | |
| NO881629L (no) | Anvendelse av antigene stoffer ved behandling av lidelseri mage-tarm-kanalen. | |
| DK3689D0 (da) | Fremgangsmaade til inaktivering af formeringsdygtige, filtrerbare sygdomsvaekkere i blodplasmaprodukter | |
| DK147088D0 (da) | Middel til behandling af virale infektioner i mennesker | |
| NO901396L (no) | Fytosanitaere preparater, deres fremstilling og deres anvendelse for behandling av kryptogame sykdommer. | |
| GB2179858B (en) | Compositions for treating viral skin diseases. | |
| NO903801L (no) | Alkalipullunase, mikroorganisme og fremgangsmaate ved fremstilling derav. | |
| IE820661L (en) | Carnitines | |
| IT1187642B (it) | Emoglobina a ridotti rischi da virus e procedimento per prepararla | |
| DK135588D0 (da) | Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler | |
| DK0393530T3 (da) | 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oner og -thioner og deres anvendelse til forebyggelse eller behandling af AIDS | |
| PT661058E (pt) | Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais | |
| EP0655919A4 (de) | Behandlung von virusinfektionen beim menschen. | |
| LTIP1943A (en) | Arylating agents, used in the treatment of cancerand disease caused by viral infection | |
| AU660916B2 (en) | Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours |